BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Older Mid-Pack Marathoners Show No Sustained Heart Damage

  September 30, 2010

   · 

  1 min read
• Tanezumab Helps OA, but Trials Stopped

  September 30, 2010

   · 

  1 min read
• Addition of Immunotherapy Boosts Pediatric Cancer Survival in Children With Neuroblastoma

  September 30, 2010

   · 

  1 min read
• Drug Development

  Sanofi-Aventis (France)'s Diabetes Treatment Lixisenatide Had Positive Phase Three Results

  September 30, 2010

   · 

  5 min read
• Business

  Peregrine Pharmaceuticals, Inc. and Affitech AS to Amend License Agreements to Expedite Development of Novel Fully Human Anti-VEGF Antibody AT001/R84

  September 30, 2010

   · 

  9 min read
• Pharm Country

  Hologic, Inc. Chief Executive Officer and President to Ring The NASDAQ Stock Market Opening Bell

  September 30, 2010

   · 

  1 min read
• Bio NC

  Curaxis Pharmaceutical Corp. CEO Patrick S. Smith Comments on World Alzheimer’s Report

  September 30, 2010

   · 

  1 min read
• Biotech Beach

  Bio-Matrix Scientific Group Inc. Chairman Sees Future of Stem Cell Therapies Focused on Stem Cell Repositories

  September 30, 2010

   · 

  1 min read
• Prenatal Heart Defects In Spinal Muscular Atrophy Cases Confirmed By Researchers

  September 30, 2010

   · 

  1 min read
• Drug Development

  Circassia Limited Initiates Phase II Trials Of Novel Grass And Ragweed Allergy Therapies And Advances Phase III Plans For Cat Allergy T-Cell Vaccine

  September 30, 2010

   · 

  3 min read